Physician profile
Michael Lypka
NPI 1265687719
$2,330.42
in general payments reported to CMS, 2019-2025
11 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $266 · 2021: $211 · 2022: $402 · 2023: $653 · 2024: $445 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,282.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $645.04 | 2019-2025 | |
| Polynovo North America LLC | $316.18 | 2022-2024 | Novosorb Btm |
| Davol INC. | $284.62 | 2023 | Phasix Mesh, Arista Ah Flexitip |
| Axogen | $183.59 | 2023 | Avance Nerve Graft |
| Integra Lifesciences Corporation | $166.45 | 2023 | Durasorb Monofilament Mesh |
| Rti Surgical, INC | $150.75 | 2024 | |
| Motiva USA, LLC | $142.62 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $134.10 | 2024 | |
| Stryker Corporation | $121.02 | 2021-2022 | |
| Mentor Worldwide LLC | $93.62 | 2021 | |
| Smith+Nephew, INC. | $92.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lypka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.